Blau Farmacêutica S.A.

São Paulo Stock Exchange BLAU3.SA

Blau Farmacêutica S.A. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 38.28 M

Blau Farmacêutica S.A. Net Cash Used Provided By Financing Activities is USD 38.28 M for the year ending December 31, 2023, a 159.30% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Blau Farmacêutica S.A. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -64.55 M, a -151.63% change year over year.
  • Blau Farmacêutica S.A. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 125.01 M, a 1,036.57% change year over year.
  • Blau Farmacêutica S.A. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 11.00 M, a 158.46% change year over year.
  • Blau Farmacêutica S.A. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -18.81 M, a -198.56% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
São Paulo Stock Exchange: BLAU3.SA

Blau Farmacêutica S.A.

CEO Mr. Marcelo Rodolfo Hahn
IPO Date April 19, 2021
Location Brazil
Headquarters Rodovia Raposo Tavares, 2833, km 30,5
Employees 1,900
Sector Health Care
Industries
Description

Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood-derived, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.

StockViz Staff

January 15, 2025

Any question? Send us an email